Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 370,829 | 599,691 | 122,420 | 80,304 | 73,551 |
| Marketable Securities | 803,083 | 479,369 | 206,120 | 122,882 | 136,793 |
| Receivables | 49,044 | 29,468 | 5,228 | 3,977 | 2,416 |
| Inventories | 125,445 | 83,605 | 12,813 | 0 | N/A |
| Other current assets | 77,782 | 36,511 | 26,895 | 17,380 | 35,036 |
| TOTAL | $1,426,183 | $1,228,644 | $373,476 | $224,543 | $247,796 |
| Non-Current Assets | |||||
| PPE Net | 97,024 | 43,156 | 37,801 | 37,344 | 38,501 |
| Investments And Advances | 0 | 21,809 | 4,751 | 783 | 782 |
| Intangibles | 11,574 | 14,355 | 8,076 | 6,642 | 5,891 |
| Other Non-Current Assets | 107,294 | 0 | 0 | 4,470 | 2,063 |
| TOTAL | $215,892 | $79,320 | $50,628 | $49,239 | $47,237 |
| Total Assets | $1,642,075 | $1,307,964 | $424,104 | $273,782 | $295,033 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 6,175 | 10,108 | 5,936 | 98 |
| Accounts payable and accrued liabilities | 33,829 | 8,467 | 29,690 | 20,234 | 12,408 |
| Accrued Expenses | 134,095 | 68,982 | 31,016 | 29,053 | 17,366 |
| Other current liabilities | 5,766 | 1,392 | 1,305 | 1,275 | 1,185 |
| TOTAL | $173,690 | $88,332 | $75,422 | $62,294 | $36,867 |
| Non-Current Liabilities | |||||
| Long Term Debt | 420,554 | 424,876 | 6,042 | 14,969 | 3,738 |
| Deferred Revenues | N/A | 3,316 | 3,303 | 3,303 | 3,318 |
| Other Non-Current Liabilities | 15,555 | 0 | 0 | 0 | 0 |
| TOTAL | $436,109 | $430,415 | $11,991 | $21,141 | $10,513 |
| Total Liabilities | $609,799 | $518,747 | $87,413 | $83,435 | $47,380 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,292 | 64,978 | 54,813 | 45,666 | 41,312 |
| Common Shares | 7 | 6 | 5 | 5 | 4 |
| Retained earnings | -1,578,926 | -1,217,008 | -1,166,320 | -899,055 | -679,025 |
| Other shareholders' equity | -99 | -379 | -120 | -111 | -95 |
| TOTAL | $1,032,276 | $789,217 | $336,691 | $190,347 | $247,653 |
| Total Liabilities And Equity | $1,642,075 | $1,307,964 | $424,104 | $273,782 | $295,033 |